Several are already delivering weight loss above 20%, while Lilly's investigational triple agonist retatrutide has reported mean weight loss of 28.3% after 80 weeks in Phase III and up to 30.3% after 104 weeks in the ongoing TRIUMPH program, further raising the bar for obesity treatment
Dehydration: When your body loses more water than it takes in, it can cause a drop in blood pressure
Smart protocol design and proactive management strategies can significantly reduce their impact
Why do many Filipinas choose Ishin Beauty
Additional risk factors are detailed in the Company's periodic filings with the SEC, including those listed in the "Risk Factors" section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q
In some cases, the risks to your kidneys may outweigh the benefits, and a different type of treatment may be a better option